Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy With PBSC Support for SCLC
NCT00003860Phase 2Completed
- Sponsor
- Unicancer
- Start
- Sep 1998
- Primary completion
- Aug 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, carboplatin, etoposide in small cell lung cancer (SCLC), sponsored by Unicancer. Started Sep 1998; status: completed.
02
Drugs
ifosfamidecarboplatinetoposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00003860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003860.